Doylestown, PA, United States of America

Michael Joseph Sofia

This inventor holds 34 USPTO granted patents and 15 published patent applications, plus 7 CIPO patents and 18 EPO patents, primarily in Nucleoside Chemistry. Top assignees: Gilead Pharmasset LLC, Gilead Sciences, Inc., Pharmasset, Inc.. Active years: 2011-2024.

USPTO Granted Patents = 34 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 24

Forward Citations = 1,556(Granted Patents)


Location History:

  • Doylestown, MN (US) (2015)
  • Doylestown, PA (US) (2011 - 2023)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleoside Phosphoramidate
Antiviral Agents
Cyclic Phosphates
Purine Nucleosides
Synthesis
Nucleoside Analogs
Modified Nucleosides
Stereoselective Synthesis
34 patents (USPTO):Explore Patents

Title: Michael Joseph Sofia: Pioneering Advances in Nucleoside Phosphoramidate Prodrugs

Introduction: Michael Joseph Sofia is a notable inventor based in Doylestown, PA, who has made significant contributions to the field of pharmaceuticals, particularly in the area of viral infection treatments. With an impressive portfolio of 34 patents, Sofia's work continues to impact medical research and drug development.

Latest Patents: Among his latest patents, Sofia has developed innovative phosphoramidate prodrugs of nucleoside derivatives aimed at treating viral infections in mammals. These compounds, including their stereoisomers, salts (both acid and basic addition salts), hydrates, solvates, or crystalline forms, are represented by a specific structure. Furthermore, the patents detail methods of treatment, uses, and processes for preparing these compounds, which are essential for advancing therapeutic options against viral infections.

Career Highlights: Throughout his career, Michael Joseph Sofia has worked at prestigious organizations such as Gilead Pharmasset LLC and Gilead Sciences, Inc. His contributions in these roles have been instrumental in health-related innovations, particularly in the realm of biotechnology and pharmaceuticals.

Collaborations: Sofia's collaborative efforts with colleagues like Jinfa Du and Peiyuan Wang have further enhanced the research and development processes within his field. These partnerships have led to significant advancements in understanding viral treatment methodologies.

Conclusion: Michael Joseph Sofia stands out as a prominent figure in the innovation landscape. His dedication to developing new pharmaceutical compounds and methods showcases the critical role inventors play in the advancement of medical science, ultimately improving treatment options for patients worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…